The director of the Medical Oncology Service at the National Cancer Institute discussed the START-001 trial.
James Gulley, MD, PhD, FACP
Advertisement
Articles by James Gulley, MD, PhD, FACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
4
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
5
